Innovation Pharmaceuticals Inc (IPIX)

[Yooper61]

I believe they did say they didn’t want to jeopardize the statistical integrity of the trial. That means they did not break the blind; they didn’t look and not tell. I’ve asked fudsters many times…why no look? My answer is they had blinded data from the CRFs that did not show a strong signal of efficacy at 6 weeks. So what? Show any data from ANY other study that 6 week data is a predictor of 12 or 16 week efficacy. Otezal was studied at 12 weeks in mid-stage trials and went to 16 weeks in P3. Was Otezla’s 6 week data strong?

As they became aware of blinded 6 week data, they also became aware of the data on patients that reached 12 weeks. If blinded 12 week data was weak, they would have broken the blind to verify. They didn’t break the blind, and they proceeded to spend another $3.3M. Look at what Protagonist just did. Mgmt is not nearly as stupid as you make them out to be.